RMHB Rocky Mountain High Brands, Inc.

Korean Seafood Makes Waves in Seattle Bring out the chopsticks, ‘cause Korean seafood just took Seattle by storm with the Cuisine.K Korean culinary showcase. Hosted by CJ Foods, alongside the Korea Fisheries Association, this event smacked the local food scene square in the face with the unique flavors and techniques of K-Seafood—from students all the way to seasoned...

Century's Earnings Call Delay Rattles Investors Century Casinos, Inc. (NASDAQ: CNTY) just hit the pause button on its much-anticipated Q3 2026 earnings call, and let me tell you, this kind of move messes with investors' minds in ways numbers can't predict. Announcing they'll be filing an extension under Rule 12b-25, they've left the specifics hanging in the air, like an...

Beverage Giant Keurig Dr Pepper Selling Big on Stock In the latest twist from the executive suite of Keurig Dr Pepper (NASDAQ: KDP), they've just pushed out a hefty public offering of nearly 58 million shares at $34.50 a pop. We're talking over a two billion dollar game plan here, folks. The deadline for this brew of equity grabs ends November 16, 2026, if all the...

Olympus Secures Reimbursement for Vital GI Procedure When it comes to navigating the health sector, you learn to spot the plays that set the stage for long-term change. Olympus Corporation just announced something worth your attention if you're eyeing the med-tech world. The Centers for Medicare & Medicaid Services (CMS) have greenlit reimbursement rates for the...

SEMIFIVE's Order Surge: An Investor's Triumph Throw the confetti and pop the champagne, SEMIFIVE just shellacked its previous records with a blistering 437% year-over-year increase in new orders for the third quarter of 2026. We're talking a leap from KRW 33.2 billion last year to a staggering KRW 178.4 billion this time around. These aren't just numbers on a spreadsheet;...

Navigating the Q3 Highs and Lows When you look at Willamette Valley Vineyards, it feels like they're stuck on a tricky grapevine. Their Q3 results for 2026 dropped like a brick, showing a $0.33 loss per share. It's a carbon copy of last year's blues, without any sweet surprise. Now don't get me wrong, the 6.6% revenue bump is a peach, but all we got was a slightly rosier...

A Unique Partnership Between Cars and Compassion Los Angeles is no stranger to the vibrant blend of culture and cars. This year, the Los Angeles Auto Show decided to steer things to a new lane of compassion by teaming up with PetSet. Now, if you're scratching your head wondering how the automobile world rides in tandem with animal welfare, grab a seat. The 'Road to Home...

Uniting Forces for Educational Empowerment You see, when philanthropic giants like the Roberto Clemente Foundation and savvy edu-tech players like Everfi decide to join hands, big things tend to happen, and Puerto Rico’s students might just be on the brink of something game-changing. Beyond the Baseball Field What the late Roberto Clemente achieved with a baseball and a...

Essity Doubling Down on Hygiene Hygiene is something you can't compromise on, and Essity gets that. They're shelling out a cool SEK 850 million into their production facility at Lilla Edet in Sweden—no small change, even in the grand scheme of corporate investment. Why the Massive Investment? It's not just about throwing money around; this move is strategic. Essity’s...

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Exciting Developments in ASC47 Research Ascletis Pharma Inc. is making significant strides in the realm of obesity treatment with its promising candidate, ASC47. This innovative drug is designed to be an adipose-targeted, muscle-preserving solution aimed at tackling obesity. Recent Phase Ib studies have provided compelling pharmacokinetic data and weight loss outcomes,...

USAA Federal Savings Bank Faces Regulatory Scrutiny The U.S. Office of the Comptroller of the Currency (OCC) has recently directed USAA Federal Savings Bank to rectify several regulatory deficiencies classified as unsafe. These issues, which the bank has grappled with for a number of years, reflect gaps in management practices, earnings strategies, information technology...

RoosterBio and Thermo Fisher: A Game-Changing Collaboration RoosterBio, Inc., a prominent supplier of adult human mesenchymal stem/stromal cells (hMSCs), has announced a strategic collaboration with Thermo Fisher Scientific. This partnership aims to enhance the manufacturing processes for groundbreaking cell and exosome therapies, promising to make significant advances in...

Nvidia's Positive Outlook for Datacenter Revenues in Q4 Analysts from Bernstein are feeling optimistic about Nvidia’s (NASDAQ: NVDA) datacenter revenues as the fourth quarter approaches. Their analysis indicates that we can anticipate a significant rise in revenue, driven by recent advancements in Nvidia's product lineup. Insights from Recent Discussions After a...

Understanding Longevity Disparities Among Older Adults A recent analysis has revealed a stark reality concerning older adults and their financial stability. Research indicates that those earning $20,000 or less annually tend to die on average nine years earlier than individuals earning $120,000 or more. This significant disparity highlights the urgent need to address the...